IL33 and serum lipopolysaccharide activity: To study whether IL‐33 could alleviate the hyperinflammation caused by PANX1 deficiency during endotoxemia, we pretreated the Panx1−/− → WT mice with recombinant IL‐33 (rIL‐33) 12 h before LPS injection.